5-Methylcytosine (5-mC) Monoclonal Antibody [33D3]

Remove paraffin with xylene or substitute, then rehydrate through graded alcohols to water.

• Incomplete deparaffinization causes patchy staining.

Use heat-induced epitope retrieval in citrate, EDTA, or another validated retrieval buffer.

• Choose retrieval pH based on antibody datasheet or optimization.

Block endogenous peroxidase for HRP detection and block non-specific tissue binding.

• Use serum or protein blocker matched to the detection system.

Apply IHC-validated 5-Methylcytosine (5-mC) Monoclonal Antibody [33D3] at the recommended dilution and incubation time.

• Run positive and negative tissue controls.

Add detection reagent, develop chromogen, counterstain, dehydrate if required, clear, and mount.

• Stop chromogen development before background becomes excessive.

Bring frozen sections to the recommended temperature and fix if not already fixed.

• Use acetone, methanol, or paraformaldehyde only if compatible with the target.

Wash gently and block non-specific binding.

• Handle sections carefully because frozen tissue can detach or tear.

Incubate with antibody validated for frozen tissue or IHC where possible.

Use chromogenic or fluorescent detection matched to the experimental goal.

Counterstain appropriately and mount using medium compatible with detection method.

Use FFPE or frozen tissue preparation appropriate to the target and antibody.

Perform antigen retrieval if needed and block tissue background.

• Reduce autofluorescence if the tissue type requires it.

Use validated primary antibodies and confirm species compatibility for multiplex staining.

Use cross-adsorbed fluorophore-conjugated secondary antibodies and protect from light.

Mount with anti-fade medium and acquire images with channel-specific exposure settings.

Use a known positive tissue and a known negative tissue before interpreting experimental samples.

Compare retrieval buffer pH and time without changing every variable at once.

Test a small dilution series around the datasheet recommendation.

Run no-primary and isotype or negative reagent controls if appropriate.

Once signal and background are acceptable, keep retrieval, antibody dilution, incubation time, and detection time consistent.

Lyse cells or tissue under cold, non-denaturing conditions when native antibody recognition is required. Clarify lysate thoroughly before adding antibody or beads.

• Use fresh protease inhibitors and phosphatase inhibitors when modification state matters.
• Save an input aliquot before the IP.

Incubate lysate with control beads to reduce proteins that bind beads non-specifically.

• Pre-clearing is especially useful with sticky lysates, tissue extracts, or high-abundance proteins.
• Keep the pre-cleared lysate as the starting material for the antibody pull-down.

Incubate lysate with the IP antibody under conditions that preserve the target epitope.

• Use an antibody validated or suitable for immunoprecipitation when available.
• Run an IgG control antibody in parallel.

Add Protein A, Protein G, or compatible beads, then wash enough to reduce background without losing target.

• Choose bead type based on antibody species and isotype.
• Increase wash stringency only after confirming target recovery.

Elute bound protein using a method compatible with the downstream assay.

• For Western blot, account for antibody heavy chain near 50 kDa and light chain near 25 kDa.
• Use light-chain-specific, conformation-specific, or directly conjugated detection if antibody chains interfere.

Use a gentle, non-denaturing lysis buffer and keep samples cold. Avoid harsh detergents or salt conditions that disrupt the interaction.

• Use fresh inhibitors and minimize processing time.
• Save input lysate for comparison with the pull-down.

Use an antibody against the bait protein or tag. Confirm that the antibody recognizes the native or minimally denatured protein.

• Use mock, untransfected, knockout, or IgG controls when possible.
• Include reciprocal co-IP when interpretation is important.

Incubate lysate with antibody and beads under gentle mixing conditions.

• Avoid overmixing or long incubations that increase background.
• Keep bead volume consistent between test and control IPs.

Wash under conditions strong enough to remove background but mild enough to preserve the interaction.

• Increase wash salt or detergent only if background is high.
• If the partner signal disappears, reduce wash stringency first.

Elute complexes and analyze by Western blot or another downstream method.

• Probe for the bait to confirm pull-down efficiency.
• Probe for the partner to assess interaction enrichment over controls.

Crosslink cells or tissue when required, quench, lyse, and isolate chromatin under conditions compatible with the target.

• Use fresh inhibitors and keep samples cold.
• For histone marks, confirm whether native or crosslinked ChIP is the better fit for the assay design.

Fragment chromatin to the target size range by sonication or enzymatic shearing.

• Check shearing before IP to avoid poor resolution or inefficient enrichment.
• Over-shearing can damage epitopes or reduce recovery.

Incubate sheared chromatin with a ChIP-suitable antibody and compatible beads.

• Include input DNA and IgG control.
• Use positive and negative genomic loci for qPCR validation when possible.

Wash beads to remove non-specific chromatin, then reverse crosslinks if crosslinking was used.

• Use wash buffers appropriate to the target and antibody strength.
• Excessively harsh washes can reduce enrichment.

Purify ChIP DNA and analyze by qPCR, sequencing, or another validated readout.

• Compare enrichment to input and IgG control.
• Evaluate both positive and negative loci before scaling up.

Lyse cells under conditions that preserve RNA-protein interactions while limiting RNA degradation.

• Use RNase-free reagents, tubes, and tips.
• Add RNase inhibitors and keep samples cold.

Pre-clear lysate with control beads and save an input aliquot for normalization.

• Input is required to distinguish enrichment from RNA abundance.
• Include IgG control IP to measure non-specific RNA binding.

Incubate lysate with antibody and beads under conditions that preserve the RNA-protein interaction.

• Use an antibody that recognizes the target protein in native or RIP-compatible conditions.
• Keep incubation consistent between test and control IPs.

Wash beads to remove non-specific material while preserving enriched RNA complexes.

• Increase stringency carefully if background RNA is high.
• Excessive washing can reduce true RNA recovery.

Release complexes, purify RNA, and analyze by RT-qPCR, sequencing, or another RNA readout.

• Include no-RT controls where appropriate.
• Normalize to input and compare against IgG control.

Grow cells to appropriate density, wash gently with PBS, and fix with paraformaldehyde or another validated fixative.

• Start with 4% paraformaldehyde for 10-15 minutes for many targets.
• Use cold methanol only when it preserves the target and epitope.

Permeabilize only when detecting intracellular or nuclear targets.

• Start with 0.1-0.3% Triton X-100 or saponin depending on target location.
• Skip or reduce permeabilization for surface antigens.

Block with serum or protein blocker matched to the secondary antibody system.

• Use serum from the secondary antibody host species when appropriate.
• Use Fc block for immune cells when non-specific Fc binding is likely.

Add 5-Methylcytosine (5-mC) Monoclonal Antibody [33D3] at validated IF dilution, wash, then add fluorophore-conjugated secondary antibody protected from light.

• Include no-primary control.
• Use highly cross-adsorbed secondary antibodies for multiplex IF.

Add nuclear counterstain if needed, mount with anti-fade medium, and image using non-saturating exposure settings.

• Use the same exposure settings for comparison groups.

Bring sections to the correct temperature, outline tissue, and wash gently to remove storage medium or embedding residue.

Use fixation or antigen retrieval appropriate to the tissue preparation and target epitope.

• Frozen tissue often needs gentler fixation.
• Fixed tissue may require antigen retrieval.

Block non-specific binding and reduce autofluorescence if tissue background is high.

• Include tissue-only and secondary-only controls.

Apply 5-Methylcytosine (5-mC) Monoclonal Antibody [33D3], wash thoroughly, then add fluorophore-conjugated secondary antibody.

• Protect slides from light after fluorophore addition.

Counterstain nuclei if needed, mount with anti-fade medium, and image using matched settings across samples.

Select primary antibodies from different host species or use directly conjugated antibodies when species overlap.

• Choose fluorophores with minimal spectral overlap.

Run each antibody alone before combining them.

• Confirm expected localization and signal strength.
• Check bleed-through using single-color controls.

Block carefully and incubate primary antibodies together only after individual staining is validated.

Use highly cross-adsorbed secondary antibodies matched to each primary species.

• Add secondary-only controls for each channel.

Image channels sequentially when possible and keep settings consistent for comparisons.

Fix quickly and consistently. Use inhibitors during sample handling when appropriate.

Modification-specific epitopes can be sensitive to fixation conditions.

• Compare paraformaldehyde and methanol only if needed.

Use a blocker compatible with the antibody and modification.

• Use no-primary, untreated, and treated controls where possible.

Compare signal with pathway stimulation, inhibitor treatment, enzyme treatment, knockdown, or known positive samples when possible.

Use identical acquisition settings for treated and untreated groups.

Dilute capture antibody in coating buffer and add to a high-binding ELISA plate. Incubate overnight at 4 C or for the validated coating time.

• Use matched antibody pairs when available.
• Keep coating volume consistent across wells.

Remove coating solution and block unoccupied binding sites with a validated blocking buffer.

• Start with 1-5% BSA, casein, or another ELISA-compatible blocker.
• Block long enough to reduce background without masking capture antibody activity.

Add standard curve, blanks, controls, and diluted samples. Incubate long enough for target binding.

• Run standards in duplicate or triplicate.
• Dilute complex samples to reduce matrix effects.

Add detection antibody that binds a different epitope than the capture antibody.

• Use biotinylated or enzyme-conjugated detection antibody when appropriate.
• Optimize detection antibody concentration if background is high.

Add enzyme conjugate if needed, wash thoroughly, add substrate, stop reaction, and read absorbance or signal according to the detection chemistry.

• Read within the recommended time window.
• Use the linear portion of the standard curve for quantification.

Dilute purified antigen in coating buffer and add to the ELISA plate.

• Use enough antigen for binding without excessive non-specific background.
• Include uncoated or irrelevant-antigen wells.

Block the plate with an ELISA-compatible blocker.

• Choose a blocker that does not cross-react with the sample antibody or secondary antibody.

Add serum, hybridoma supernatant, purified antibody, or other antibody-containing sample.

• Run a dilution series for unknown samples.
• Include positive and negative controls.

Add secondary antibody matched to the species and isotype of the sample antibody.

• Use cross-adsorbed secondary antibodies when specificity matters.
• Optimize secondary dilution to reduce background.

Add substrate, stop reaction if required, and read the plate.

• Compare signal to blank, negative control, and antigen-free wells.
• For screening, rank samples by signal-to-background ratio.

Add purified target, lysate, sample, modified molecule, or kit-specified coating material to the plate and incubate under validated conditions.

Block wells to reduce non-specific binding.

• Include blank or background-control wells to measure plate and reagent background.

Add the kit-specified detection reagent, directly labeled antibody, or enzyme-conjugated antibody diluted in the recommended buffer.

• Start with datasheet or kit guidance and run a dilution series when optimizing a new assay.

Wash enough to remove unbound detection reagent.

• High background is often improved by dilution, blocking, and wash optimization.

Add substrate, monitor color development, stop reaction if required, and read signal.

Choose whether sample target competes with coated antigen or labeled target for limited antibody binding.

• Keep the competition design consistent across standards and unknowns.

Prepare a standard curve covering the expected concentration range.

• Competitive ELISA signal often decreases as target concentration increases.

Incubate antibody with standards or samples according to the chosen competitive design.

Wash the plate, add detection reagent or substrate as required, and read signal.

Fit the standard curve using the appropriate competitive model and interpret inverse signal behavior.

• Do not interpret competitive ELISA like sandwich ELISA.